Literature DB >> 21866385

Mitral valve disease in Marfan syndrome and related disorders.

Daniel P Judge1, Rosanne Rouf, Jennifer Habashi, Harry C Dietz.   

Abstract

Marfan syndrome (MFS) is a systemic disorder of the connective tissue with pleiotropic manifestations due to heterozygous FBN1 mutations and consequent upregulation of TGFβ signaling in affected tissues. Myxomatous thickening and elongation of the mitral valve (MV) leaflets commonly occur in this condition. Investigation of murine models of this disease has led to improved understanding of the mechanisms that underlie many of the phenotypic features of MFS, including MV disease. Loeys-Dietz syndrome (LDS) is a related disorder due to heterozygous mutations in the genes encoding subunits of the TGFβ receptor, and it may also involve the MV leaflets with similar elongation and thickening of the MV leaflets. Although the genetic basis and pathogenesis of nonsyndromic MV prolapse has been elusive to date, insights derived from monogenic disorders like MFS and LDS can be informative with regard to novel gene discovery and investigation into the pathogenesis of MV disease. This manuscript will review the prevalence of MV disease in MFS, its pathogenic basis as determined in mice with Fbn1 mutations, and ongoing studies that seek to better understand MV disease in the context of fibrillin-1 deficiency or excessive TGFβ signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21866385     DOI: 10.1007/s12265-011-9314-y

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  46 in total

Review 1.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

2.  The cardiovascular aspects of Marfan's syndrome: a heritable disorder of connective tissue.

Authors:  V A McKUSICK
Journal:  Circulation       Date:  1955-03       Impact factor: 29.690

3.  Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism.

Authors:  Juan Rodríguez-Vita; Elsa Sánchez-López; Vanesa Esteban; Mónica Rupérez; Jesús Egido; Marta Ruiz-Ortega
Journal:  Circulation       Date:  2005-05-09       Impact factor: 29.690

4.  Recurrent and founder mutations in the Netherlands: Extensive clinical variability in Marfan syndrome patients with a single novel recurrent fibrillin-1 missense mutation.

Authors:  J J J Aalberts; A G Schuurman; G Pals; B J C Hamel; G Bosman; Y Hilhorst-Hofstee; D Q C M Barge-Schaapveld; B J M Mulder; M P van den Berg; J P van Tintelen
Journal:  Neth Heart J       Date:  2010-02       Impact factor: 2.380

5.  Diagnosis and management of infantile marfan syndrome.

Authors:  R P Morse; S Rockenmacher; R E Pyeritz; S P Sanders; F R Bieber; A Lin; P MacLeod; B Hall; J M Graham
Journal:  Pediatrics       Date:  1990-12       Impact factor: 7.124

6.  Aneurysm syndromes caused by mutations in the TGF-beta receptor.

Authors:  Bart L Loeys; Ulrike Schwarze; Tammy Holm; Bert L Callewaert; George H Thomas; Hariyadarshi Pannu; Julie F De Backer; Gretchen L Oswald; Sofie Symoens; Sylvie Manouvrier; Amy E Roberts; Francesca Faravelli; M Alba Greco; Reed E Pyeritz; Dianna M Milewicz; Paul J Coucke; Duke E Cameron; Alan C Braverman; Peter H Byers; Anne M De Paepe; Harry C Dietz
Journal:  N Engl J Med       Date:  2006-08-24       Impact factor: 91.245

7.  Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.

Authors:  Emma S Jones; M Jane Black; Robert E Widdop
Journal:  J Mol Cell Cardiol       Date:  2004-11       Impact factor: 5.000

8.  Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.

Authors:  Anthony H Barnett; Stephen C Bain; Paul Bouter; Bengt Karlberg; Sten Madsbad; Jak Jervell; Jukka Mustonen
Journal:  N Engl J Med       Date:  2004-10-31       Impact factor: 91.245

9.  Mitral valve prolapse in Marfan syndrome: an old topic revisited.

Authors:  Cynthia C Taub; Joan M Stoler; Teresa Perez-Sanz; John Chu; Eric M Isselbacher; Michael H Picard; Arthur E Weyman
Journal:  Echocardiography       Date:  2008-11-24       Impact factor: 1.724

10.  The relationship of mitral annular shape to the diagnosis of mitral valve prolapse.

Authors:  R A Levine; M O Triulzi; P Harrigan; A E Weyman
Journal:  Circulation       Date:  1987-04       Impact factor: 29.690

View more
  15 in total

Review 1.  Mitral valve disease--morphology and mechanisms.

Authors:  Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2015-10-20       Impact factor: 32.419

2.  Enlarged Dural Sac in Idiopathic Bronchiectasis Implicates Heritable Connective Tissue Gene Variants.

Authors:  M Leigh Anne Daniels; Katherine R Birchard; Jared R Lowe; Michael V Patrone; Peadar G Noone; Michael R Knowles
Journal:  Ann Am Thorac Soc       Date:  2016-10

Review 3.  Potential drug targets for calcific aortic valve disease.

Authors:  Joshua D Hutcheson; Elena Aikawa; W David Merryman
Journal:  Nat Rev Cardiol       Date:  2014-01-21       Impact factor: 32.419

Review 4.  Connective tissue disorders and cardiovascular complications: the indomitable role of transforming growth factor-beta signaling.

Authors:  Jason B Wheeler; John S Ikonomidis; Jeffrey A Jones
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 5.  Cardiovascular Management of Adults with Marfan Syndrome.

Authors:  Yukiko Isekame; Sabiha Gati; Jose Antonio Aragon-Martin; Rachel Bastiaenen; Sreenivasa Rao Kondapally Seshasai; Anne Child
Journal:  Eur Cardiol       Date:  2016-12

Review 6.  Pathophysiology and Pathogenesis of Marfan Syndrome.

Authors:  Sanford M Zeigler; Brandon Sloan; Jeffrey A Jones
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Connective Tissue Disorders and Cardiovascular Complications: The Indomitable Role of Transforming Growth Factor-β Signaling.

Authors:  Jason B Wheeler; John S Ikonomidis; Jeffrey A Jones
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Critical roles of miRNA-mediated regulation of TGFβ signalling during mouse cardiogenesis.

Authors:  Yin Peng; Lanying Song; Mei Zhao; Cristina Harmelink; Paige Debenedittis; Xiangqin Cui; Qin Wang; Kai Jiao
Journal:  Cardiovasc Res       Date:  2014-05-16       Impact factor: 10.787

Review 9.  Macrophage lineages in heart valve development and disease.

Authors:  Andrew J Kim; Na Xu; Katherine E Yutzey
Journal:  Cardiovasc Res       Date:  2021-02-22       Impact factor: 10.787

Review 10.  Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.

Authors:  Cortney Gensemer; Randall Burks; Steven Kautz; Daniel P Judge; Mark Lavallee; Russell A Norris
Journal:  Dev Dyn       Date:  2020-08-17       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.